Skip to main content
. 2013 Aug 26;8(8):e72804. doi: 10.1371/journal.pone.0072804

Figure 5. Schematic representation of the pathways regulating the frequencies of Th17/Treg cell populations in ACS.

Figure 5

IL-6-activated STAT3 signaling upregulates RORγt to promote Th17 cell differentiation through naïve T cells. High levels of TGF-β1 in ACS patients promote Treg cells differentiation but may inhibit Th17 cell differentiation. Imbalanced Th17 and Treg cell frequencies in ACS patients may originate from the reciprocal modulations by IL-6 and TGF-β1.